A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer (DB-07)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04538742

Recruitment Status : Active, not recruiting

First Posted : September 4, 2020

Last Update Posted : June 7, 2023

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Daiichi Sankyo Company, Limited

Information provided by (Responsible Party):

AstraZeneca

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	January 31, 2025
Estimated Study Completion Date :	July 2, 2025

To Top